Kharkiv Regional Clinical Oncology Center, Day Care Unit

Kharkiv, Kyivskyi District 61070

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer With Low to Intermediate HER2 Expression

Studies at this site

• Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence — Completed